Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation
Authors:
Open Access
- 29 August 2012
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 53 (10) , 1534-1542
Abstract
The purpose of this study was to investigate the diagnostic performance of 2 newly developed dedicated breast PET scanners in patients with known or suspected breast cancer. Methods: Two types of scanner were evaluated, an O-shaped scanner and a C-shaped scanner. The O scanner was designed for imaging patients who were prone, and the C scanner was designed for those patients positioned leaning forward. Sixty-nine women with known or suspected breast carcinoma (80 lesions: 72 invasive carcinomas, 4 noninvasive carcinomas [ductal carcinoma in situ, or DCIS], 1 case of adenomatous ductal hyperplasia, and 3 benign lesions) were enrolled in this study. All patients underwent a conventional whole-body PET/CT scan, followed by breast scanning using both dedicated devices. The diagnostic performance of each scanner was assessed. Results: The maximal diameter of invasive tumors ranged from 4 to 112 mm, with an average of 26 mm. With the O scanner, 62 of 76 malignant lesions (including 3 DCIS) were detected, 5 lesions were not detected, and the remaining 9 lesions were outside the field of view. With the C scanner, 63 of 76 malignant lesions (including 2 DCIS) were detected, 7 lesions were not detected, and the remaining 6 lesions were outside the field of view. The lesion-based sensitivities of the O and C scanners were 82% (62/76) and 83% (63/76), respectively; sensitivities excluding lesions outside the field of view were 93% (62/67) and 90% (63/70), respectively. The sensitivity of conventional PET/CT was 92% (70/76). All lesions outside the field of view were close to the chest wall. The breast-based specificities of the O, C, and conventional scanners were 98% (48/49), 98% (56/57), and 100% (70/70), respectively. Conclusion: Our preliminary study indicates that both dedicated breast PET scanners are clinically feasible and yield reasonably high sensitivity. More detailed information was obtained with these scanners than with the conventional scanner.Keywords
This publication has 28 references indexed in Scilit:
- Cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- Initial Characterization of a Dedicated Breast PET/CT Scanner During Human ImagingJournal of Nuclear Medicine, 2009
- A systematic review of FDG-PET in breast cancerMedical Oncology, 2009
- FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesionsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Comparison of scintillators for positron emission mammography (PEM) systemsIEEE Transactions on Nuclear Science, 2003
- Positron Emission Mammography: Initial Clinical ResultsAnnals of Surgical Oncology, 2003
- Beyond randomized controlled trialsCancer, 2001
- Dedicated PET scanners for breast imagingPhysics in Medicine & Biology, 1997
- Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.Radiology, 1993
- Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1991